Adam Laponis Eargo, Inc. (EAR) insider trading activity

Adam Laponis is Chief Financial Officer of Eargo, Inc.. Currently has a direct ownership of 258 shares of EAR, which is worth approximately $18,189. The most recent transaction as insider was on Nov 20, 2023, when has been sold 33 shares (Common Stock) at a price of $2.6 per share, resulting in proceeds of $85. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 258

0% 3M change

0% 12M change

Total Value Held $18,189

Adam Laponis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 20 2023	SELL Sale (or disposition) back to the issuer	$85 $2.6 p/Share	33 Reduced 11.34%	258 Common Stock
Nov 17 2023	SELL Sale (or disposition) back to the issuer	$48 $2.56 p/Share	19 Reduced 6.13%	291 Common Stock
Nov 15 2023	SELL Sale (or disposition) back to the issuer	$7,247 $2.55 p/Share	2,842 Reduced 90.16%	310 Common Stock
Aug 17 2023	SELL Open market or private sale	$61 $3.24 p/Share	19 Reduced 0.6%	3,152 Common Stock
May 17 2023	SELL Open market or private sale	$89 $4.69 p/Share	19 Reduced 0.6%	3,171 Common Stock
Feb 17 2023	SELL Open market or private sale	$154 $7.37 p/Share	21 Reduced 0.65%	3,190 Common Stock
Nov 22 2022	BUY Exercise of in-the-money or at-the-money derivatives securities	$2,497 $0.5 p/Share	4,995 Added 7.22%	64,222 Common Stock
Nov 17 2022	SELL Open market or private sale	$357 $0.52 p/Share	687 Reduced 1.15%	59,227 Common Stock
Aug 15 2022	SELL Payment of exercise price or tax liability	$407 $1.14 p/Share	357 Reduced 0.59%	59,914 Common Stock
May 31 2022	SELL Payment of exercise price or tax liability	$1,107 $1.55 p/Share	714 Reduced 1.17%	60,271 Common Stock
Mar 09 2022	SELL Payment of exercise price or tax liability	$1,696 $4.01 p/Share	423 Reduced 0.69%	60,985 Common Stock
Mar 09 2022	SELL Sale (or disposition) back to the issuer	$2,438 $4.01 p/Share	608 Reduced 0.98%	61,408 Common Stock
Aug 17 2021	SELL Payment of exercise price or tax liability	$8,810 $24.54 p/Share	359 Reduced 0.58%	62,016 Common Stock
Jun 29 2021	SELL Open market or private sale	$384,300 $38.43 p/Share	10,000 Reduced 14.17%	60,568 Common Stock
Jun 29 2021	BUY Exercise of conversion of derivative security	$25,500 $2.55 p/Share	10,000 Added 12.41%	70,568 Common Stock
May 17 2021	SELL Payment of exercise price or tax liability	$12,301 $33.98 p/Share	362 Reduced 0.59%	60,568 Common Stock
Jan 29 2021	BUY Grant, award, or other acquisition	-	16,500 Added 21.31%	60,930 Common Stock
Oct 20 2020	BUY Conversion of derivative security	-	11,097 Added 19.98%	44,430 Common Stock

Also insider at

TWST

Twist Bioscience Corp Healthcare

Chief Financial Officer

Adam Laponis

Chief Financial Officer

San Jose, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EAR shares.

Notify only if

Value

Insider Trading

Get notified when an Eargo, Inc. insider buys or sells EAR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Eargo, Inc.

Track Activities on EAR

Account